piero pollesello
piero pollesello
Orion Pharma
Email verificata su orionpharma.com
Titolo
Citata da
Citata da
Anno
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
R Longo, P Pollesello, C Ricci, F Masutti, BJ Kvam, L Bercich, LS Croce, ...
Journal of Magnetic Resonance Imaging 5 (3), 281-285, 1995
4201995
Noninvasive in vivo quantitative assessment of fat content in human liver
C Ricci, R Longo, E Gioulis, M Bosco, P Pollesello, F Masutti, LS Crocč, ...
Journal of hepatology 27 (1), 108-113, 1997
3611997
Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.
P Pollesello, M Ovaska, J Kaivola, C Tilgmann, K Lundström, N Kalkkinen, ...
Journal of Biological Chemistry 269 (46), 28584-28590, 1994
2481994
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan
Z Papp, I Édes, S Fruhwald, SG De Hert, M Salmenperä, H Leppikangas, ...
International journal of cardiology 159 (2), 82-87, 2012
2412012
Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels
P Kaheinen, P Pollesello, J Levijoki, H Haikala
Journal of cardiovascular pharmacology 37 (4), 367-374, 2001
1912001
Biochemical and immunohistochemical evidence that in cartilage an alkaline phosphatase is a Ca2+-binding glycoprotein.
B De Bernard, P Bianco, E Bonucci, M Costantini, GC Lunazzi, ...
The Journal of cell biology 103 (4), 1615-1623, 1986
1591986
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan
Z Papp, K Csapó, P Pollesello, H Haikala, I Édes
Cardiovascular drug reviews 23 (1), 71-98, 2005
1562005
Levosimendan is a mitochondrial KATP channel opener
DM Kopustinskiene, P Pollesello, NEL Saris
European journal of pharmacology 428 (3), 311-314, 2001
1542001
Binding of levosimendan, a calcium sensitizer, to cardiac troponin C
T Sorsa, S Heikkinen, MB Abbott, E Abusamhadneh, T Laakso, ...
Journal of Biological Chemistry 276 (12), 9337-9343, 2001
1532001
Levosimendan: current data, clinical use and future development
MS Nieminen, S Fruhwald, LMA Heunks, PK Suominen, AC Gordon, ...
Heart, lung and vessels 5 (4), 227, 2013
1422013
The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig
S Szilágyi, P Pollesello, J Levijoki, P Kaheinen, H Haikala, I Édes, Z Papp
European journal of pharmacology 486 (1), 67-74, 2004
1262004
Potassium-specific effects of levosimendan on heart mitochondria
DM Kopustinskiene, P Pollesello, NEL Saris
Biochemical pharmacology 68 (5), 807-812, 2004
1252004
A role for the RISK pathway and KATP channels in pre‐ and post‐conditioning induced by levosimendan in the isolated guinea pig heart
EF Du Toit, A Genis, LH Opie, P Pollesello, A Lochner
British journal of pharmacology 154 (1), 41-50, 2008
1212008
Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anaesthetic propofol
O Eriksson, P Pollesello, NEL Saris
Biochemical Pharmacology 44 (2), 391-393, 1992
1211992
The cardioprotective effects of levosimendan: preclinical and clinical evidence
P Pollesello, Z Papp
Journal of cardiovascular pharmacology 50 (3), 257-263, 2007
1122007
The patient perspective: quality of life in advanced heart failure with frequent hospitalisations
MS Nieminen, K Dickstein, C Fonseca, JM Serrano, J Parissis, F Fedele, ...
International journal of cardiology 191, 256-264, 2015
1012015
The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c
T Sorsa, P Pollesello, RJ Solaro
Molecular and cellular biochemistry 266 (1-2), 87-107, 2004
1002004
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion
W Toller, M Heringlake, F Guarracino, L Algotsson, J Alvarez, ...
International Journal of Cardiology 184, 323-336, 2015
992015
Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart
P Kaheinen, P Pollesello, J Levijoki, H Haikala
Journal of cardiovascular pharmacology 43 (4), 555-561, 2004
992004
Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan
J Levijoki, P Pollesello, J Kaivola, C Tilgmann, T Sorsa, A Annila, ...
Journal of molecular and cellular cardiology 32 (3), 479-491, 2000
902000
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20